BELL vs. IUG, IHC, RUA, NCYT, OBD, SBTX, VRCI, HEMO, RENX, and OBI
Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Intelligent Ultrasound Group (IUG), Inspiration Healthcare Group (IHC), RUA Life Sciences (RUA), Novacyt (NCYT), Oxford BioDynamics (OBD), SkinBioTherapeutics (SBTX), Verici Dx (VRCI), Hemogenyx Pharmaceuticals (HEMO), Renalytix (RENX), and Ondine Biomedical (OBI). These companies are all part of the "medical" sector.
Intelligent Ultrasound Group (LON:IUG) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings, dividends and community ranking.
Intelligent Ultrasound Group has higher revenue and earnings than Belluscura. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.
76.9% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 15.0% of Belluscura shares are held by institutional investors. 13.4% of Intelligent Ultrasound Group shares are held by insiders. Comparatively, 48.1% of Belluscura shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Belluscura's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.
Intelligent Ultrasound Group has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.
Intelligent Ultrasound Group and Belluscura both received 0 outperform votes by MarketBeat users.
Belluscura has a net margin of 0.00% compared to Belluscura's net margin of -23.11%. Belluscura's return on equity of -23.58% beat Intelligent Ultrasound Group's return on equity.
Summary
Intelligent Ultrasound Group beats Belluscura on 6 of the 11 factors compared between the two stocks.
Get Belluscura News Delivered to You Automatically
Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Belluscura Competitors List
Related Companies and Tools
